| Primary |
| Transplant Rejection |
13.5% |
| Kawasaki's Disease |
11.5% |
| Acute Disseminated Encephalomyelitis |
7.7% |
| Heart Block Congenital |
7.7% |
| Immune Thrombocytopenic Purpura |
7.7% |
| Guillain-barre Syndrome |
5.8% |
| Idiopathic Thrombocytopenic Purpura |
5.8% |
| Immunodeficiency Common Variable |
5.8% |
| Autoimmune Haemolytic Anaemia |
3.8% |
| Demyelinating Polyneuropathy |
3.8% |
| Neuromyelitis Optica |
3.8% |
| Neuropathy Peripheral |
3.8% |
| Status Epilepticus |
3.8% |
| Thrombocytopenia |
3.8% |
| Chronic Inflammatory Demyelinating Polyradiculoneuropathy |
1.9% |
| Complex Regional Pain Syndrome |
1.9% |
| Encephalitis |
1.9% |
| Encephalopathy |
1.9% |
| Heart Disease Congenital |
1.9% |
| Hemophagocytic Syndrome |
1.9% |
|
| Drug Ineffective For Unapproved Indication |
16.3% |
| Urine Output Decreased |
14.0% |
| Off Label Use |
7.0% |
| Pyrexia |
7.0% |
| Respiratory Disorder |
7.0% |
| Drug Ineffective |
4.7% |
| Exposure During Pregnancy |
4.7% |
| Maternal Exposure During Pregnancy |
4.7% |
| Neuropathy Peripheral |
4.7% |
| Respiratory Failure |
4.7% |
| Transfusion-related Acute Lung Injury |
4.7% |
| Cholestasis |
2.3% |
| Deep Vein Thrombosis |
2.3% |
| Drug Effect Decreased |
2.3% |
| Dyspnoea |
2.3% |
| Maternal Drugs Affecting Foetus |
2.3% |
| Meningitis |
2.3% |
| Multi-organ Failure |
2.3% |
| Mycoplasma Infection |
2.3% |
| Necrotising Colitis |
2.3% |
|
| Secondary |
| Product Used For Unknown Indication |
25.0% |
| Crohn's Disease |
8.3% |
| Infantile Spasms |
8.3% |
| Acute Disseminated Encephalomyelitis |
5.6% |
| Infection Prophylaxis |
5.6% |
| Migraine |
5.6% |
| Antiviral Prophylaxis |
4.2% |
| Back Pain |
4.2% |
| Immunosuppression |
4.2% |
| Kawasaki's Disease |
4.2% |
| Chronic Inflammatory Demyelinating Polyradiculoneuropathy |
2.8% |
| Duodenal Ulcer |
2.8% |
| Immunodeficiency Common Variable |
2.8% |
| Monoclonal Gammopathy |
2.8% |
| Multiple Sclerosis |
2.8% |
| Myasthenia Gravis |
2.8% |
| Nausea |
2.8% |
| Plasma Cell Myeloma |
2.8% |
| High Pulse Rate |
1.4% |
| Amyotrophic Lateral Sclerosis |
1.4% |
|
| Vomiting |
22.2% |
| Drug Ineffective For Unapproved Indication |
11.1% |
| Night Sweats |
11.1% |
| Fungal Skin Infection |
5.6% |
| Hyperparathyroidism Secondary |
5.6% |
| Kawasaki's Disease |
5.6% |
| Neck Pain |
5.6% |
| Optic Ischaemic Neuropathy |
5.6% |
| Premature Baby |
5.6% |
| Refusal Of Treatment By Patient |
5.6% |
| Tremor |
5.6% |
| Urinary Tract Disorder |
5.6% |
| Urine Analysis Abnormal |
5.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.0% |
| Drug Use For Unknown Indication |
23.3% |
| Multiple Sclerosis |
10.7% |
| Plasma Cell Myeloma |
4.7% |
| Premedication |
4.0% |
| Crohn's Disease |
3.3% |
| Granulomatosis With Polyangiitis |
3.3% |
| Pain |
3.3% |
| Idiopathic Thrombocytopenic Purpura |
3.0% |
| Off Label Use |
2.7% |
| Depression |
2.3% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Prophylaxis |
2.0% |
| Asthma |
1.7% |
| Maternal Exposure Timing Unspecified |
1.7% |
| Multiple Sclerosis Relapse |
1.7% |
| Antiviral Treatment |
1.3% |
| Nausea |
1.3% |
| Neuropathy Peripheral |
1.3% |
| Renal Transplant |
1.3% |
|
| Vomiting |
19.4% |
| Off Label Use |
8.3% |
| Pain In Extremity |
5.6% |
| Pancytopenia |
5.6% |
| Platelet Count Decreased |
5.6% |
| Pneumonia |
5.6% |
| Progressive Multifocal Leukoencephalopathy |
5.6% |
| Pyrexia |
5.6% |
| Sepsis |
5.6% |
| Weight Decreased |
5.6% |
| Anaemia |
2.8% |
| Anaphylactic Reaction |
2.8% |
| Blood Alkaline Phosphatase Increased |
2.8% |
| Bone Marrow Reticulin Fibrosis |
2.8% |
| Deep Vein Thrombosis |
2.8% |
| Drug Eruption |
2.8% |
| Drug Ineffective |
2.8% |
| Extravasation |
2.8% |
| Fatigue |
2.8% |
| Gastrointestinal Viral Infection |
2.8% |
|
